The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
about
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Functio Laesa: Cancer Inflammation and Therapeutic Resistance.Associations of tumor regression grade with outcomes in patients with locally advanced rectal cancer treated with preoperative two-week course of radiotherapy.Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer.Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival.Preoperative platelet-lymphocyte ratio is an independent prognostic factor in ampullary carcinoma following pancreaticoduodenectomy
P2860
The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The Pretreatment Systemic Infl ...... vant Therapy for Rectal Cancer
@en
The Pretreatment Systemic Infl ...... ant Therapy for Rectal Cancer.
@nl
type
label
The Pretreatment Systemic Infl ...... vant Therapy for Rectal Cancer
@en
The Pretreatment Systemic Infl ...... ant Therapy for Rectal Cancer.
@nl
prefLabel
The Pretreatment Systemic Infl ...... vant Therapy for Rectal Cancer
@en
The Pretreatment Systemic Infl ...... ant Therapy for Rectal Cancer.
@nl
P2093
P2860
P50
P1476
The Pretreatment Systemic Infl ...... vant Therapy for Rectal Cancer
@en
P2093
Ashita Waterston
James J Going
Paul G Horgan
P2860
P2888
P304
P356
10.1245/S10434-016-5684-3
P577
2016-11-21T00:00:00Z
P6179
1064470818